CHYM vs CLBT: fair value comparison
Chime Financial, Inc. and Cellebrite DI Ltd. · Updated 2026-10-19
CHYM's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Technology, CHYM currently ranks higher by quality score.
| CHYM | CLBT | |
|---|---|---|
| Verdict | Awaiting full valuation | Undervalued |
| Last price | $29.67 | $11.03 |
| 12-month range | $16.44–$34.55 | $10.44–$19.28 |
| Rank by discount to fair value | — | #26 of 181 Technology |
| Rank by quality score | #20 of 274 Technology | #21 of 274 Technology |
| Quality grade | A | A |
| Leverage | Low | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | High | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The upper-middle quarter | The bottom quarter |
Full single-stock breakdowns: CHYM fair value analysis · CLBT fair value analysis